title: [Percutaneous transluminal coronary angioplasty (PTCA) as primary therapy in acute myocardial infarct].
abstract: OBJECTIVE
  Percutaneous transluminal coronary angioplasty (PTCA) is being increasingly considered as an alternative to thrombolytic treatment of acute myocardial infarction. Studies performed so far, some on selected groups of patients, have produced high initial results of success. This prospective study was undertaken to determined primary success, complications and recurrence after primary PTCA in acute myocardial infarction (AMI).
  
  
  METHODS
  Primary treatment in the form of immediate PTCA of the infarct vessel was undertaken in 111 patients (84 men, 27 women; mean age 58.6 +/- 10.3 years) with AMI. PTCA was judged successful if the infarct vessel had been reopened to perfusion grade 3 and restenosis was < 50%. No thrombolytic treatment was given, but heparin infusions were given during and for 24-48 hours after the procedure. 13 patients (11.7%) were in cardiogenic shock or required cardiopulmonary resuscitation for infarct-related arrhythmias.
  
  
  RESULTS
  The primary success rate of PTCA for the whole group was 91% (101 of 111 patients), but only 77% (ten of 13) among patients in cardiogenic shock and (or) after resuscitation. Acute re-occlusion (0-6 days after PTCA) occurred in seven patients. Eight patients (7.2%) died during the hospital phase (0-4 weeks), seven of whom had been in shock or required resuscitation (death rate 54%). The overall complication rate of the intervention was 6.3%. No emergency aortocoronary bypass was necessary. Repeat coronary angiography was performed in 71 of the 101 successfully treated patients 6 or 12 weeks after the PTCA. Re-occlusion was demonstrated in four (5.6%), a restenosis of more than 50% in 25% of patients. Mean left ventricular ejection fraction, obtained by planimetry from the levocardiogram was 58.6 +/- 9.3%.
  
  
  CONCLUSIONS
  PTCA, performed immediately after acute myocardial infarction is an effective therapeutic measure with a high primary success rate.
authors.affiliation: Medizinische Klinik--Schwerpunkt für Kardiologie, Nephrologie und Intensivmedizin, St.-Johannes-Hospital, Dortmund.
authors.forename: I
authors.initials: I
authors.lastname: Krakau
authors.forename: N
authors.initials: N
authors.lastname: Schulze-Waltrop
authors.forename: R
authors.initials: R
authors.lastname: Arens
authors.forename: W
authors.initials: W
authors.lastname: Willgeroth
authors.forename: H
authors.initials: H
authors.lastname: Heuer
mesh_terms: D000368:Aged; D000787:Angina Pectoris / Q000175:diagnosis / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data; D017023:Coronary Angiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000628:therapy*; D011446:Prospective Studies; D012008:Recurrence; D012770:Shock, Cardiogenic / Q000175:diagnosis / Q000628:therapy; D013997:Time Factors
vernacular_title: Perkutane transluminale Koronarangioplastie (PTCA) als Primärtherapie beim akuten Myokardinfarkt.